. Knockdown of SMN using single siRNA oligonucleotide against SMN and its effect on DNA Damage activation in non-SMA dividing cells. HeLa cells were untransfected (Control) or transfected with siRNA 100 nM) against SMN1 (siSMN-D23) or scrambled siRNA sequence (Scramble) and incubated for 30 h. Cells were harvested for protein extraction or fixed and stained with antibodies for immunoblot and immunofluorescence analysis. (a) Immunoblot analysis of SMN and a-tubulin proteins in Control, siSMN and Scramble treated cells. (b) Cell stained with SMN (green) and phospho-H2AX (gH2AX) (red). Nuclei were stained with DAPI. Immunofluorescence of stained cells was examined by confocal microscopy. Scale bar is 10 µm. Figure S2 . Acute SMN deficiency (knockdown) causes DNA damage and activation of DNA damage response (DDR) pathways, and accumulation of R-loops in non-SMA dividing cells (low magnification images). HeLa cells were untransfected (Control) or transfected with siRNA (100 nM) against SMN1 (siSMN) or scrambled siRNA sequence (Scramble) and incubated for 30 h. Cells were fixed and stained with antibodies against marker proteins of sub-nuclear bodies, (a) SMN (green) and phospho-H2AX (gH2AX) (red), (b) SMN (green) and phospho-DNA-PKcs (pDNAPKcs) (red) and (c) accumulation of RNA-DNA hybrids (R-loops) in SMN-deficient cells. R-loops were detected by monoclonal antibody (S9.6) against RNA-DNA hybrids (green). Coilin is a control stained in red. Nuclei were stained with DAPI. Immunofluorescence of stained cells was examined by confocal microscopy. Scale bar is 25 µm. (a) HeLa cells were untransfected (Control) or transfected with siRNA 100 nM) against SMN1 or scrambled siRNA sequence (Scramble) and incubated for 30 h. Cells were harvested and total RNA was isolated (3 cell lysates/group), cDNA was generated using reverse transcriptase PCR and examined by Real-Time PCR using SYBR green method and hSETX primers. Quantitative and statistical (ANOVA) analysis of transcript levels shows decrease (23.80 ± 3.22%, p = 0.000) in SETX transcripts in SMN-deficient HeLa cells. (b) RNA was isolated from dividing non-SMA human cells, WI-38 and GM03814 (Normal), and SMA patient dividing cells, GM03813 and GM09677 (SMA) and examined by Real-time PCR (3 cell lysates/cell-line). Analysis of transcript show decrease (23.82 ± 3.66%, p = 0.001) (GM03813) and (25.81 ± 3.94%, p = 0.001) (GM09677) in SETX transcript levels in SMA patient cells compared to normal GM03814 cells. Figure S5 . Chronic low levels of SMN cause DNA damage in in fibroblasts (dividing cells) derived from SMA patients. Cultured fibroblasts (dividing cells) derived from human (WI-38), non-SMA (Normal) and SMA type I (Werdnig-Hoffmann disease) patients, GM03813, GM09677 (SMA), were stained with antibodies against (c) Control and siRNA transfected HeLa cells (siSMN) were fixed and labeled with modified dUTP (EdU) nucleotide to detect strand breaks by TUNEL staining (red). SMN is stained in green and nuclei stained with DAPI (blue). Immunofluorescence of stained cells was examined by confocal microscopy. Scale bar is 25 µm. HeLa cells were untransfected (Control) or transfected with siRNA 100 nM) against SMN1 or scrambled siRNA sequence (Scramble) and incubated for 30 h. Cells were harvested and total RNA was isolated (3 cell lysates/group), cDNA was generated using reverse transcriptase PCR and examined by Real-Time PCR using SYBR green method and DNA-PKcs primers. Quantitative and statistical (ANOVA) analysis of transcript levels shows decrease (13.41 ± 4.85%, p = 0.050) in DNA-PKcs transcripts in SMN-deficient HeLa cells. (b) RNA was isolated from dividing non-SMA human cells, , and SMA patient dividing cells, GM03813 and GM09677 (SMA) and examined by Real-time PCR (3 cell lysates/cell-line). Analysis of transcripts show decrease (35.15 ± 4.69%, p = 0.000) (GM03813) and (31.34 ± 4.40%, p = 0.000) (GM09677) in DNA-PKcs transcript levels in SMA patient cells compared to normal WI-38 cells. 
